In the present study, 10 clinical isolates of dengue virus were selected according to their susceptibility to the inhibitory effect of nitric oxide radical, NO. Five of them are nitric oxide-susceptible viruses while the other five are nitric oxide-resistant viruses. These isolates were investigated to identify genetic factors that are responsible for the different phenotypes. Due to the evidence showing that NO suppresses DENV RNA polymerase activity, we, therefore, hypothesized that the RdRp domain of NS5 may responsible for NO inhibition. To answer this question, sequences of NS5 gene of NO-susceptible viruses and NO-resistant viruses were compared. We found that these two groups of viruses contain different amino acid sequence at position 621 to 646 in the active site of NS5. These data suggested that response to the inhibitory effect of nitric oxide radical may, at least in part, be regulated by NS5. The effect of these two different phenotypes of viruses on host cells was studied using cDNA array screening. The cDNA array analysis demonstrated that the nitric oxide-resistant group had a stronger influence on host cells since it induced changes in the expression of a greater number of genes than did the nitric oxide-susceptible group, 97 genes versus 71 genes, respectively. The NO-resistant virus also stimulated cytokines known to be virulent factors, such as IL 6, IL 8, RANTES, and the inflammatory factors. In conclusion, our data demonstrated that dengue viruses isolated from patients show genotypic and phenotypic differences which may correlate with virulence.
Introduction
Dengue is the most common arthropod-borne viral disease caused by a single-stranded, positive-sense RNA virus of the genus Flavivirus named dengue virus (DENV). Infection by DENV can cause a subclinical infection or an illness with severity ranging from flu-like symptoms to classical dengue fever with or without lifethreatening manifestation. The classical dengue fever, DF, is a selflimiting illness with an abrupt onset of fever, headache, retro-ocular pain, muscle and joint pain, nausea, vomiting and rashes that may be associated with moderate hemorrhagic manifestations. It is estimated that less than 3% of symptomatic patients develop a lifethreatening syndrome presenting with hemorrhage and shock, the dengue hemorrhagic fever or DHF (Halstead, 1980) . Severe clinical manifestations are believed to be the result of a complex interplay between different factors including viral strain, circulating viral particles and viral antigens, the host, and the vector. This has been extensively reviewed elsewhere (Pang et al., 2007 ; de la C Sierra et al., 2007; Halstead, 2008) .
DENV is composed of four genetically and antigenetically related serotypes. Each serotype of DENV contains abundant genetic variation and can be subdivided into subtypes or genotypes. Among those genotypes, the Southeast Asian genotype presents the greatest amount of genetic diversity (Holmes, 2006) . This genotypic variation may partly explain the differential severity of clinical symptoms in a dengue-immune population, as shown by epidemiological observations (Kouri et al., 1998; Rico-Hesse et al., 1997) . For example, the Southeast Asian genotype, but not its American counterpart, is frequently associates with severe infection (Watts et al., 1999) . Even though the genetic basis of this difference is unclear, the two genotypes differ by ten charged amino acids in both structural and nonstructural proteins. Some of these differences affect replication efficiency and transmission rate in human cell, the primary target, and the mosquito vector (Cologna et al., 2005; Cologna and Rico-Hesse, 2003) .
We recently showed that sensitivity to the inhibitory effect of nitric oxide radical might be another criterion to distinguish clinical isolates of dengue viruses since replication of 60% of clinical isolates, 24 out of 40 isolates, were suppressed in the presence of nitric oxide, NO, synthesized from 50 µM SNAP while the remaining 16 isolates replicate unaffectedly under the same treatment (Charnsilpa et al., 2005) . The target of nitric oxide on dengue virus replication is unclear but there is evidence suggesting that this free radical may exert its inhibitory effect through inhibition of RdRp activity (Takhumpanya et al., 2006) . Given that some target cells of the virus, such as monocytes and macrophages produce NO, the difference of the viruses in vulnerability to nitric oxide may affect the clinical outcome of patients.
In the present study, 10 isolates of dengue virus from DF and DHF patients, 5 isolates from each, were investigated. The 5 DF isolates are NO-sensitive viruses while the other 5 DHF isolates are NO-resistant. The genotypic differences of the NS5 gene between these two groups were investigated at the level of amino acid sequence. In addition, differences in global gene expression of NO-producing host cells in response to infection by the two groups of isolates were monitored using a cDNA array analysis. We demonstrate that the response of the dengue virus to the inhibitory effect of free radical may be regulated by the NS5 gene. We also show here that NO-resistant viruses have a stronger influence on gene expression of the infected host cells in both the number and the type of genes. The relationship between the gene expression patterns and the clinical manifestations of viral isolates is discussed.
Results
The effect of endogenous nitric oxide on the replication of NO-susceptible and NO-resistant DENV-2
The kinetics of replication of these two groups of clinical isolates was investigated in THP-1 cells in the presence or absence of 100 µM L-NIL, a specific inhibitor of iNOS. As demonstrated in Figs. 1a and b, NO-susceptible isolates replicated less efficiently than the NOresistant viruses in the presence of endogenous NO synthesized from infected THP-1 cells. However, these two groups of viruses replicated equally well when endogenous NO synthesis was significantly suppressed in the presence of 100 µM L-NIL (Figs. 1a and b) . These results indicate that nitric oxide has a profound effect only on the replication of NO-sensitive dengue viruses but not on NOresistant viruses.
NS5 is responsible for susceptibility to nitric oxide
Our previous report suggests that NO might exert its inhibitory effect through suppression of NS5 activity (Takhumpanya et al., 2006) . We, therefore, hypothesized that amino acids in the virus genome, particularly in the active site of NS5, might determine the resistance/sensitivity to NO. To answer this question, amino acids responsible for resistance/sensitivity to NO were predicted. Two domains of NS5, amino acid 211 to 458 in the MTase domain and amino acid 598 to 749 of the active site of RdRp domain, were sequenced (Yap et al., 2007) . These were then aligned with the published sequence of DENV-2 (Asian I genotype, Vietnam strain) using BioEdit (Version7.0.5.2). As shown in Fig. 2a , differences of amino acid sequence at position 621 to 646 were found between susceptible and resistant groups and among viruses within the resistant group. The sequences of amino acid 211 to 458 in the MTase domain were also aligned and a strong homology was found (Fig. 2b) . These data suggested that NS5 domain 621 to 646 may be, at least in part, responsible for the different phenotypes.
cDNA array analysis of gene expression profile in THP-1 cells infected with either NO-susceptible or NO-resistant isolates
The above data suggests that the efficiency of replication of these two groups of isolates is different in NO-producing THP-1 cells. To verify the impact of these two groups of isolates on host responses, the cDNA analysis was used to compare the patterns of THP-1 gene expression in response to infection by either of these two groups of viruses. Genes that exhibited twofold increase or decrease in expression against the uninfected THP-1 control cells in three independent experiments were considered significant (Table 1) . Among the dysregulated genes, twelve were affected by both groups of virus isolates while 59 were affected only by the NO-susceptible DENV and 85 only by the NO-resistant DENV.
Since pathophysiology of DENV infection is mainly affected by immunological mediators, we focused on the alteration in immune response genes. Tables 2 and 3 show the list of immune response transcripts on the cDNA array that were activated or suppressed by either group of viruses. The expression of 21 and 41 immune response-related genes was affected by the infection of NO-susceptible and NO-resistant viruses, respectively.
These results indicate that the NO-resistant viruses have a broader effect on THP-1 gene expression than do the NO-susceptible viruses.
Validation of cDNA array analysis by RT-PCR
To validate the cDNA array data, 13 genes (CD40L, DAF, IL-3R, IL-4R, IL-6, IL-8, IRF-2, LFA-3, NK4, PBP, ELAM-1, GP-1A and GP-3A) were selected for RT-PCR analysis. THP-1 cells were infected with either NOresistant or NO-susceptible virus or mock-infected. Then, the expression levels of selected genes were determined on day 3 of infection. The observed expression levels relative to β-actin gene expression are shown in Table 4 . The level of gene expression detected by RT-PCR confirmed the up-or down-regulation of these 13 genes as demonstrated by cDNA array analysis. Replication kinetics of NO-resistant and NO-susceptible isolates in the presence and absence of iNOS inhibitor, L-NIL. THP-1 cell cultures were infected with either group of isolates at the MOI of 1.0. Virus production was monitored up to five days of infection in the presence or absence of L-NIL (a). The level of NO production in the culture medium was determined by using a colorimetric kit (b). Three independent experiments were performed and data are shown as mean ± SD. (⁎) indicates statistically significance at P value less than 0.05.
Validation of cDNA array analysis by ELISA
To confirm the array data at the protein level, production of IL-6 and RANTES in culture supernates from uninfected and virus-infected THP-1 cells were quantitated by ELISA. As demonstrated in Figs. 3a-b, IL-6 and RANTES productions were stronger in NO-resistant infected cells than in NO-susceptible infected cells. These data agree with the cDNA array expression detection. 
Discussion
Each year, more than 50 million people are infected by DENV and around 500,000 cases develop a severe disease, DHF/DSS (World Health Organization, 2002) . Several models have been proposed to explain the progression of clinical manifestation into the severe form. These models focus on the role of host and viral factors in increased pathogenesis (Green and Rothman, 2006) . Our present report gives another piece of evidence for the role of viral factor on the severity of dengue infection. Two groups of low passages of clinical isolates which express a distinct phenotype on response to nitric oxide radical were investigated in the present study. We found that these clinical isolates behaved differently in NO-producing target cells, THP-1. The NO-resistant group replicated more efficiently than those NOsensitive viruses. Our sequencing data revealed significant differences on amino acid composition in one domain of an active site of NS5 suggesting that NS5 is one part of genetic factor that determines NOsensitive or NO-resistant phenotype. The present data supports evidence demonstrated by Takhumpunya et al that NS5 might be a target of NO (Takhumpanya et al., 2006) .
The NO-resistant viruses had stronger influence on host genetic response than did the NO-susceptible ones. Higher replication and stronger influence on the global host gene expression are characteristics found in virulent DENV (Rabablert et al., 2007; Butrapet et al., 2000; Yoksan et al., 1986) . Whether NS5 determines severity of DENV infection or not remains to be elucidated. The investigation of DENV evolution in Cuba found dominant nucleotide substitution in NS5 but not in structural genes during a severe dengue epidemic in 1997 (Rodriguez-Roche et al., 2005) . Thus, in order to draw a correlation between the NS5 genotype and its contribution to disease severity, more investigation on NS5 genetic manipulation is required.
To further distinguish between the two groups of clinical isolates, differences in viral-host interaction were investigated at the genomic level. The cDNA data indicated that NO-resistant isolates had a stronger influence on the expression of immune response-related genes than did NO-susceptible isolates. The NO-resistant virus up-regulated cytokines/chemokines genes and genes involving an activation of T cells, B cells, platelets, and inflammatory cells. Functions of these mediators may result in the interaction between platelets, vascular endothelial cells, and inflammatory cells (Martin et al., 2007) . This interaction is critical for the vascular events including vascular leakage.
Another striking difference between the two groups of isolates is that NO-resistant isolates significantly up-regulated IL-6, IL-7, IL-8, RANTES, and MCP-3. These factors have been shown to be correlated with an increased dengue pathogenesis through various mechanisms. IL-6, in its high concentration, plays a crucial role in the enhanced production of anti-platelet or anti-endothelial cell auto-antibodies, an elevated level of tPA, as well as a deficiency in coagulation (Akira et al., 1993) . A high level of plasma IL-6 is found in DHF/DSS patients but not in DF patients (Nguyen et al., 2004; Lee et al., 2007) . A study on DENV infection of human primary lung epithelial cell in vitro suggests that IL-6 may be involved in plural effusion and hemorrhage through the induction of sPLA2 synthesis by lung epithelial (Lee et al., 2007) . IL-8 destroys tight-junction and cytoskeleton reorganization, resulting in increased permeability of microvascular endothelial monolayers during DENV infection (Tabavera et al., 2004) .
RANTES is a chemokine that is synthesized by various types of cells infected by DENV (Suksanpaisan et al., 2007; Huang et al., 2000) . This chemokine induces NK cells activation, and serves as a chemotaxis which stimulates trans-endothelial migration of various inflammatory cells (Appay and Rowland-Jones, 2001; Middleton et al., 2002) . MCP-3 is a pleiotropic chemokine that is important in regulating immune cell trafficking and function (Ali et al., 2005) . Significant upregulation of RANTES and MCP-3 gene expression in cells infected with NO-resistant viruses implies an enhancement of immune cells, including inflammatory cells, and the movement to the infected sites where tissue damages are induced.
These data suggest that NO-resistant isolates preferentially stimulated cytokines/chemokines that are potent mediators of tissue damaging as well as the coagulopathy while the NO-susceptible viruses did not. The difference may underline intrinsic properties of the clinical isolates. This observation is supported by the evidence that DENV-induced cytokine pattern is dependent on serotype and strain (Azizan et al., 2006) . The balance between virus elimination and tissue damaging effects of these immune mediators will determine the severity of infection.
Infection by NO-resistant viruses markedly induced genes involved in immune suppression such as IL-7 and CD83 (Fry and Mackall, 2001; Luthje et al., 2006) . IL-7 is strongly associated with CD4+ T cell lymphopenia in HIV infected patients and also plays an important role in the inflammation and the immunopathology of rheumatoid arthritis (Napolitano et al., 2006; Hartgring et al., 2006) . High expression of IL-7 and CD83 might imply an inefficiency in DENV clearance during an acute phase of infection by the NO-resistant virus.
In conclusion, our present investigation demonstrated that the patient isolates of DENV-2 have different intrinsic properties which can be illustrated using efficiency of replication and the stimulation patterns of immune response genes related to increased pathogenesis. Our observations suggested that clinical isolates of DENV resistant to NO have a higher potential to cause severe clinical symptoms than did NO-susceptible isolates. Whether or not these phenotypes are determined by the differences in genotypic characteristics of NS5 should be investigated further. a Genes that were up-or down-regulated by both groups of DENV isolates. b Genes that were up-or down-regulated by either NO-susceptible DENV or NOresistant DENV infection. 
Up-regulation

Materials and methods
Virus and cell culture Virus
Ten out of 40 isolates previously described by Charnsilpa et al. were selected for the present study (Charnsilpa et al., 2005) . Of the ten isolates, 5 were NO-sensitive viruses isolated from DF patients and the other 5 were NO-resistant viruses isolated from DHF patients. These viruses were low-passage isolates of DENV-2 obtained from Virology Department, Armed Forces Research Institute of Medical Science, Bangkok, Thailand. Viruses from patients were first amplified in Toxorhynchitis splendens mosquitoes and were then amplified twice in C6/ 36 cells.
Cell culture
THP-1 cells were obtained from American Type Culture Collection (ATCC, Rockwell, MD). The cells were cultured in Iscove-modified Dulbecco's medium (IMDM) supplemented with 10% fetal bovine serum, FBS (Gibco Labs, Grand Island, NY) at 37°C in 5% CO 2 atmosphere.
Inoculation of THP-1 culture
NO-susceptible and NO-resistant DENV were inoculated into 10 6 cells of THP-1 at the MOI of 1.0. After 1.5 h of inoculation at 37°C, the infected cells were washed and cultured further in the growth medium. The supernatants and infected cells were harvested every 24 h for 5 days. Supernatants were then subjected to detection of viral genome production using real-time RT-PCR, NO production, and cytokines production by ELISA. Harvested cells were used for cDNA array analysis and for detection of gene expression by RT-PCR. Table 3 List of immune response genes and immune response-related genes with expressions statistically up-or down-regulated during NO-resistant virus infection
Gene descriptions
Fold change (±S.D.)
Up-regulation
Platelet membrane glycogrotein (IIA) (GP3A) 4.2 ± 2.0 CD44 antigen hematopoietic form (CD44H) 4.7 ± 1.9 E-selectin (ELAM-1) 3.9 ± 2.1 Leukocyte adhesion glycoprotein p150 84.3 ± 34.2 Monocyte differentiation CD14 antigen 16.0 ± 4.1 L-selectin 5.3 ± 2.2 Cytotoxic T-lymphocyte protein-4 (CTLA-4) 7.1 ± 2.6 Leukocyte surface CD53 antigen 5.5 ± 1.0 CD9 antigen 3.1 ± 1.4 T-lymphocyte activations CD86 antigen 40.3 ± 15.8 CD83 antigen 14.28 ± 4.3 Beta chemokine exodus 2 4.0 ± 15.8 IL-2 receptor beta (IL2RB) 3.3 ± 1.8 Interleukin 6 (IL-6) 10.0 ± 2.0 Interleukin 7 (IL-7)
5.1 ± 3.1 Interleukin 8 13.3 ± 5.5 CD27 ligand 15.8 ± 5.4 CSF-1R 3.8 ± 1.3 T cell specific RANTES 15.21 ± 4.1 Monocyte chemotactic protein 3 (MCP3) 8.1 ± 1.0 Antileukoproteinase 1 (ALP) 17.5 ± 6.4 IgA Fc receptor (FcAR) 14.9 ± 6.6 T cell differentiation CD6 antigen 3.6 ± 1.4 B-cell antigen receptor 35.5 ± 12.3 Signal transducer and activator of transcription 2 (STAT 2) 3.2 ± 1.6 Interferon regulatory factor 4 (IRF-4) 67.13 ± 23.9 T cell maturation-associated protein (MAL) 2.3 ± 1.2 Hematopoietic lineage cell specific protein 22.8 ± 8.6
Down-regulation LFA-1 alpha 0.32 ± 0. 0.9 ± 0.05 3.9 ± 2.1 1.1 ± 0.22 2.5 ± 0.1 GP1A 5.1 ± 2.4 0.6 ± 0.1 3.5 ± 1.4 0.9 ± 0.1 GP3A 0.7 ± 0.2 4.2 ± 2.0 0.8 ± 0.06 3.0 ± 0.06 Fig. 3 . Validation of array data using ELISA. The levels of IL-6 (a) and RANTES (b) in infected culture medium were quantitated using ELISA. Supernatants from the uninfected cultures were used as controls. (⁎) indicates significantly difference at the P value ≤ 0.05.
Viral RNA copy number titration by fluorogenic real-time RT-PCR RNA was extracted from culture supernatants using the NucleoSpin ® RNA Virus Kit (Macherey-Nagel, Germany). The purified RNA was then subjected to RT-PCR using QuantiTect ™ Probe RT-PCR (QIAGEN GmbH, Germany) as described (Houng et al., 2000) . RT-PCR amplification, data collection and analysis were performed by Rotor-Gene ™ 3000 (Corbett Research, Sydney, Australia). The RNA copy number was calculated using dengue serotype specific copy standards kindly supplied by Dr. Huo-Shu H. Houng, WRAIR (Walter Reed Army Institute of Research, USA).
Quantitative detection of nitric oxide production
The amounts of nitric oxide in the supernatants were detected by NO colorimetric Kit (Cayman Chemical Company, Ann Arbor, MI) that detects the stable products of NO, NO 2 /NO 3 . The experiment was performed according to manufacturer's protocol.
RNA extraction and cDNA array analysis
Total RNA was extracted from DENV-infected THP-1 by using the Nucleospin RNAII Kit (Macherey-Nagal, Germany) according to instructions recommended by the manufacturer. The mRNA was isolated from total RNA by using the Streptavidin Magnetic beads System (Clontech, CA, USA). The purified mRNA was reverse-transcribed and labeled with 32 P-dATP to synthesize 32 P-cDNA probes according to manufacturer's protocol. The labeled cDNA probes were hybridized to the BD Atlas ™ Human Hematology/Immunology Array (ClonTech). The expression signal of each gene was detected by autoradiography. The intensity of spots was analyzed by using ClonTech Atlas Image program version 2.7. Normalization was performed by dividing the intensities of housekeeping genes from each pair of arrays from the same day post infection, and the value obtained was used as the intensity coefficient. The adjusted intensities of spots were calculated by multiplying the spot intensity by the intensity coefficient.
To demonstrate a reliable cDNA array analysis, the reproducibility of the technique was examined and found that the correlation between two data sets was very high (R 2 = 0.981, P value is ≤0.05), confirming the high reproducibility of the technique used in this study.
Determination of gene expression by semiquantitative RT-PCR
The levels of gene expression in DENV-infected THP-1 were measured semiquantitatively by RT-PCR as previously described (Ubol et al., 1998) . Briefly, harvested cells were lysed. RNA was purified and subjected to the first strand cDNA synthesis before being further amplified by PCR. The list of specific primers for RT-PCR is shown in Table 5 . The PCR products were electrophoresed and the density of each band was measured semiquantitatively with a densitometer. The levels of gene expression were presented as fold changes in transcription between either NO-susceptible or NO-resistant DENV-infected THP-1 cells and uninfected cells by using β-actin as an internal control for gene expression.
Detection of cytokine production by ELISA
The levels of IL-6, and RANTES production in the supernatants of infected THP-1 cultures were measured using Quantikine ® ELISA kit (R&D Systems, Inc., Minneapolis, MN). Briefly, 200 µl of standards or samples were pipetted into wells precoated with polyclonal antibody specific to these cytokines. The antibody-cytokine interaction was detected using enzyme-linked polyclonal antibodies specific for these cytokines and the substrate. The intensity of the color was measured at 450 nm.
Statistical analysis
Values were expressed as mean ± standard deviation (SD) of three independent observations. The significance of differences was tested by Student's t-test, One-way ANOVA or Pearson's correlation. P value less than 0.05 is considered significant.
RNA extraction and RT-PCR to generate NS5 DNA fragments used in sequencing
Virus RNA was extracted from cell-culture supernatant by using NucleoSpin ® RNA Virus Kit (MACHEREY-NAGEL, Germany) according to the manufacturer's instruction. Oligonucleotide primers for DEN-2 NS5 gene amplification and sequencing were previously described (Balleotti et al., 2003) . Genomic RNA was reverse-transcribed into cDNA by using random-hexamer primers with the AMV-RT. DENV-2 NS5 gene was amplified by PCR with Tag DNA polymerase and the PCR product was purified and submitted for DNA sequencing. The primers for MTase domain are sense 5′ TCA AGG AAC TCC ACA CAT GAG ATG TACT 3′ and anti-sense 5′ TCT CTC TCT TTC CCA TCA TGT TGT A 3′. The primer set for RdRp domain is sense 5′ CAG TGG ACA GGT GGG AAC TT 3′ and anti-sense 5′ TCC TGC TCC CTG AGA GATTC 3′. The nucleotide sequences obtained were translated, aligned and analyzed using BioEdit (Version 7.0.5.2) (Hall, 1990) .
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